A novel truncating mutation in MYD88 in a patient with BCG adenitis, neutropenia and delayed umbilical cord separation

Clin Immunol. 2019 Oct:207:40-42. doi: 10.1016/j.clim.2019.07.004. Epub 2019 Jul 10.

Abstract

Mutations in MYD88 cause susceptibility to invasive bacterial infections through impaired signaling downstream of toll-like receptors (TLRs) and IL-1 receptors. We studied a patient presenting with neutropenia, delayed umbilical cord separation, BCG adenitis, andP. aeruginosapneumonia. Next-generation DNA sequencing identified a novel homozygous truncation mutation in MYD88 that abolishes MyD88 expression. The patient's dermal fibroblasts had severely impaired IL-6 production after stimulation with ligands for the MyD88-dependent receptors TLR2, TLR4 and IL-1R, while responses to ligands for the MyD88-independent receptors TLR3 and TNF-α were preserved. Notably, secretion of TNF-α, which is essential for BCG control, was also impaired after LPS stimulation. In this first report of BCG infection in MyD88 deficiency, data suggest that MyD88-dependent TNF-α production contributes to control of mycobacterial disease.

Keywords: BCG; Delayed umbilical cord separation; MyD88 deficiency; Neutropenia.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • BCG Vaccine / adverse effects*
  • BCG Vaccine / immunology
  • Genetic Predisposition to Disease
  • Humans
  • Lymphadenitis / pathology*
  • Male
  • Myeloid Differentiation Factor 88 / genetics*
  • Neutropenia / genetics*
  • Neutropenia / pathology
  • Pneumonia, Bacterial / microbiology*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa
  • Umbilical Cord / pathology*

Substances

  • BCG Vaccine
  • MYD88 protein, human
  • Myeloid Differentiation Factor 88